All News

With rates of stone disease on the rise in the U.S., researchers have turned their attention to possible causes. New research exploring the possible influence of diabetes, diet, and even being a surgeon will be presented at the upcoming AUA annual meeting.

Drugs and devices in the pipeline from Medivation, Inc.; Astellas Pharma Inc.; TARIS Biomedical; Exelixis, Inc.; and Bioniche Life Sciences Inc.

The latest products and services from Advanced Meditech International, Inc.; Vitacon US, LLC; Pocket Nurse Enterprises; the American College of Surgeons; and Physicians Interactive.

A new closer look at genomes in prostate cancer has revealed that genetic mutations occur in abrupt, periodic bursts, causing complex, large-scale reshuffling of DNA driving the development of the disease.

Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with nonobese men and were at a greater risk for subsequently developing prostate cancer, a recently published study found.

Two urology groups are among 64 organizations that have enrolled to be early adopters in the National Committee for Quality Assurance’s (NCQA) new patient-centered medical home evaluation program for specialists outside of primary care.

Incidence rates for prostate and other cancers are statistically higher than expected among World Trade Center rescue and recovery workers, according to a recent study.

This article discusses the role of transplantation of embryonic renal structures, two forms of scaffolds, and the role of various stem cell populations in regenerative medicine.

In the area of female urology, look for key studies at the AUA annual meeting involving sling surgery, onabotulinumtoxinA (Botox) injections, and reoperation after pelvic organ prolapse surgery with mesh.

In the area of sexual dysfunction, much of the clinical research continues to focus on medical therapies, and this will be evident at the upcoming AUA annual meeting in San Diego.

Reconstruction using commercially available porcine small intestinal submucosa as an onlay patch appears to be a reasonable alternative to buccal mucosa grafting for urethral stricture repair after failed endoscopic treatment, according to a recent study.

A new staging system for anterior urethral strictures and alternatives to oral mucosa grafts will be among the key research findings in trauma/reconstruction at the upcoming AUA annual meeting, says a leader in this urology subspecialty.

Prostate cancer patients who also have long-term diabetes mellitus and/or diabetes with organ failure may have a higher likelihood of developing more aggressive, poorly differentiated prostate cancer, a new study suggests.

Urologists discuss the potential effects of the Sunshine Act.

As waves of change in medicine erode urologists’ ability to go into and stay in traditional solo and private practices, many new urologists are opting for hospital employment.

Government and private payers, employers, and physician groups are joining the frenzy to rein in what has become out-of-control spending. Since physicians are at the frontlines prescribing care, much of the pressure to deliver cost-effective and necessary care is falling on them.

Researchers have shown, via a phase I trial, that the relationship between nerves and prostate cancer in perineural invasion is susceptible to therapeutic intervention with neurotoxic agents such as onabotulinumtoxinA (Botox).

These products and services are from manufacturers that are exhibiting at the American Urological Association annual meeting in San Diego. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.

Data from a recent multicenter study provide new evidence that the beta-3 adrenoceptor agonist mirabegron (Myrbetriq) appears to be a viable alternative in patients with overactive bladder who are poor responders to antimuscarinic agents or intolerant of their adverse events.

Transrectal anterior zone sampling of the prostate may be a viable alternative to transperineal template biopsies in patients with negative previous biopsies and with rising PSA or persistently elevated PSA, researchers from the United Kingdom report.

African-American men eligible for active surveillance have a higher risk of advanced cancer on final surgical pathology compared to Caucasian men, suggesting the need for more stringent criteria for active surveillance for African-American men, according to a recently published study.

Trigonal onabotulinumtoxinA (Botox) brings equal analgesic relief to patients with ulcerative and non-ulcerative forms of bladder pain syndrome/interstitial cystitis alike, according to the results of a recent study.

THVD-201 (Tolenix), a novel formulation combining tolterodine and pilocarpine, was found safe, well tolerated, and effective against overactive bladder (OAB) in a recent study.

A single PSA test at 45 years of age may help predict long-term risk of developing aggressive prostate cancer, according to a recent study.

Researchers at UCLA’s Institute of Urologic Oncology and department of urology have classified kidney cancer into several unique subtypes, a finding that could help physicians tailor treatment to individual patients.

Researchers at UCLA’s Institute of Urologic Oncology and department of urology have classified kidney cancer into several unique subtypes, a finding that could help physicians tailor treatment to individual patients.

EDAP TMS said the FDA has provided a positive filing review notification on the company’s pre-market approval application for its Ablatherm Integrated Imaging HIFU (high-intensity focused ultrasound) device for the treatment of low-risk, localized prostate cancer.

The aging population and an expected influx of 30 million newly insured Americans have raised concerns about provider shortages and bolstered efforts to expand the role of advanced practice practitioners (APPs) in the delivery of patient care. Unsatisfied with collaborative teams led by physicians that empower APPs and promote patient safety, organizations representing nurse practitioners, for one, are seizing this opportunity to increase the number of states where they practice without supervision.